Soft Tissue Substitutes in Perioral Augmentation

ABSTRACT

Each year the plastic surgery industry has a newer, better, soft tissue filler. Most plastic surgeons are very skeptical about the newest product. The goal is always an injectable, affordable, long-lasting filler. We have recently witnessed a dramatic increase in the available fillers for use in perioral rejuvenation. Thus, it is necessary to discuss state-of-the art fillers now available, the techniques used, potential pitfalls in use, and results. Solutions to problematic areas in perioral rejuvenation are presented. There does not appear yet to be an ideal filler; instead most plastic surgeons have an algorithm for modest, moderate, and dramatic improvement in facial soft tissue needs. Our practice has more recently focused on various combinations of Alloderm™, fat, and hydroxylapitate injectable microspheres (Radiance™) to fill most of these needs. We strongly suggest that plastic surgeons become facile with three or four fillers to address a wider range of soft tissue needs. We present an in-depth discussion of the most common available fillers and show the risks and benefits we have experienced with each.

KEYWORDS

Nasolabial fold - vermilion - autologous - Radiance™ - augmentation

REFERENCES

• 1 Lemperle G. et al .Human histology and persistence of various injectable filler substances for soft tissue augmentation. Presented at 33rd Annual Meeting of the Association of German Plastic Surgeons, Heidelberg, Germany, September 21, 2002
• 2 Terino E O. Alloderm acellular dermal graft nonoperative techniques in facial rejuvenation, II.  Clin Plast Surg . 2001;  28 83-99
• 3 Wainwright D, Nag A, Call T. et al .Normal histological features persist in an acellular dermal transplant grafted in full-thickness burns. Paper presented at The Federation of the American Society of Experimental Biology Research Conference, Saxtons River, UT, July 9-14, 1994
• 4 Lemperle G, Hazen-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft tissue augmentation, II: clinical investigations.  Plast Reconstr Surg . 1995;  96 627-634
• 5 Allen O. Response to subdermal implantation of textured microimplants in humans.  Aesthet Plast Surg . 1992;  16 227-230
• 6 Tomazic-Jezic V J, Merritt K, Umbreit T H. Significance of the type and size of the biomaterial particles on phagocytosis and tissue distribution.  J Biomat Res . 2001;  55 523-529
• 7 Lemperle G, Hazen-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for long lasting correction of wrinkles: refinements and statistical results.  Aesthet Plast Surg . 1998;  22 356-365
• 8 Lemperle G, Romano J, Busso M. Soft tissue augmentation with Artecoll: history, indications, technique and potential side effects. Summary of course given at 27th Annual Meeting of the Canadian Society of Aesthetic Plastic Surgery, Montreal, Canada, September 2000
• 9 Lemperle G. Personal communication, January 2003 . 
• 10 Lemperle G, Holmes R, Cohen S, Lemperle M. A classification of facial wrinkles.  Plast Reconstr Surg . 2001;  108 1735-1750
• 11 Livesey S A, Herndon D N, Hollyoak M A. et al . Transplanted acellular allograft dermal matrix.  Transplantation . 1995;  60 1
• 12 Isenberg J S. Further clinical experience in permanent lip augmentation using autologous breast implant capsule.  Ann Plast Surg . 1998;  40 265-267
• 13 Isenberg J S. Permanent lip augmentation using autologous breast implant capsule.  Ann Plast Surg . 1996;  37 121-124
• 14 Wall S J, Adamson P A. Augmentation, enhancement, and implantation procedures for the lips.  Otolaryngol Clin North Am . 2002;  35 87-102
• 15 American Society for Aesthetic Plastic Surgery, Inc. ASAPS 2000 Statistics on Cosmetic Surgery. Los Alamitos, CA: ASAPS 2001
• 16 Stuart J M, Huffstutter E H, Townes A S, Kang A H. Incidence and specificity of antibodies to type 1, II, III, IV, and V collagen in rheumatoid arthritis and in other rheumatic diseases as measured by 125 I-radioimmunoassay.  Arthrit Rheum . 1983;  26 832-840
• 17 Claque R B, Shaw M J, Lennox Holt J P. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis.  Ann Rheum Dis . 1980;  39 201-206
• 18 Mackel A M, DeLustro F, Harper F E. et al . Antibodies to collagen in scleroderma.  Arthrit Rheum . 1982;  25 522-531
• 19 Cukier J, Beauchamp R, Spindler J. et al . Association between bovine collagen dermal implants and a dermatomyositis polymyositis-like syndrome.  Ann Intern Med . 1993;  118 920-928
• 20 Rosenberg M, Reichlin M. Is there an association between injectable collagen and polymyositis/dermatomyositis.  Arth Rheum . 1994;  37 747-753
• 21 Henke C W, Thomas J A, Lee W T. et al . Risk assessment of polymyositis/dermatomyositis after treatment with injectable bovine collagen implants.  J Am Acad Dermatol . 1996;  34 450-454
• 22 Cooperman L S, Mackinnon V, Bechler G. et al . Injectable collagen: a six year clinical investigation.  Aesthet Plast Surg . 1985;  9 145-151
• 23 Schnitzer L, Baran R, Arrouy M. et al . Cutaneous responses to an injectable collagen. Clinical, histologic, and ultrastructural correlations after intradermal tests.  Ann Dermatol Venereol . 1984;  111 135-145
• 24 Cooperman L, Michaeli D. The immunogenicity of injectable collagen. II. A retrospective review of seventy two tested and treated patients.  J Am Acad Dermatol . 1984;  10 647-651
• 25 Delustro F, Smith S T, Sundsmo J. et al . Reaction to injectable collagen: results in animal models in clinical use.  Plast Reconstr Surg . 1987;  79 581-594
• 26 Elson M L. The role of skin testing in the use of collagen injectable materials.  J Dermatol Surg Oncol . 1989;  15 301-303
• 27 Kamer F M, Churukian A M. Clinical use of injectable collagen. A three year retrospective review.  Arch Otolaryngol . 1984;  110 93-98
• 28 Davis K, Bottone E J, Lucas D. et al . Sterility of refrigerated injectable collagen syringes after injection of patients.  J Am Acad Dermatol . 1992;  27 959-961
• 29 Culligan P J, Koduri S, Heit M H. et al . The safety of re-using injectable collagen: a multicenter microbiology study.  Int Urogynecol J Pelvic Floor Dysfunct . 2002;  13 232-235
• 30 Bergeret-Galley C, Latouche X, Illouz Y G. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep.  Aesthet Plast Surg . 2001;  25 249-255
• 31 Galli W E, LeMesurier M. The living sutures in the treatment of hernia.  Can Med J . 1923;  13 469-480
• 32 Burres S A. Lip augmentation with preserved fascia-lata.  Dermatol Surg . 1997;  23 459-462
• 33 Burres S. Soft tissue augmentation with fascia.  Clin Plast Surg . 2001;  28 101-110
• 34 Robertson K M, Deyer W K. The use of fillers in the aging patient.  Fac Plast Surg . 1996;  12 293-301
• 35 Wall S J, Adamson P A. Augmentation, enhancement and implantation procedures for the lips.  Otolaryngol Clin North Am . 2002;  35 87-102
• 36 Cisneros J L, Singla R. Intradermal augmentation with expanded polytetrafluoroethylene (Gore-Tex) for facial lines and wrinkles.  J Dermatol Surg Oncol . 1993;  19 539-542
• 37 Lassus C. Restoration of the lip roll with Gore-Tex.  Aesthet Plast Surg . 1997;  21 430-432
• 38 Davis G EM. Softform facial implants: safety and efficacy report.  Plast Reconstr Surg . 1998;  101 1988-1989
• 39 Rubin M. Personal communication. Study results of comparative trial: Restylane vs Zyplast . 
• 40 Friedman P M, Mafong E A, Kauvar A N. et al . Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation.  Dermatol Surg . 2002;  28 491-494
• 41 Lowe N J, Maxwell C A, Lowe P. Hyaluronic acid skin fillers: adverse reactions and skin testing.  J Am Acad Dermatol . 2001;  45 930-933
• 42 Manna F, Dentini M, Desideri P. et al . Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation.  J Eur Acad Dermatol Venereol . 1999;  13 183-192
• 43 Unpublished data on file.  Tissue Science Laboratories, 1998
• 44 Unpublished data on file. Tissue Science Laboratories, 1999
• 45 Amard P. PLA (New Fill) as management of lipoatrophy of the face.  Aesth Surg . 2001;  1 28
• 46 Stein J, Eliachar I, Myles J. et al . Histopathologic study of alternative substances for vocal fold medialization.  Ann Otol Rhinol Laryngol . 2000;  109 221-226
• 47 Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence.  Urology . 2001;  57 434-438
• 48 Drobeck H, Rothstein S, Gumaer K. et al . Histologic observation of soft tissue responses to implanted, multifaceted particles and discs of hydroxylapatite.  J Oral Maxillofac Surg . 1984;  42 143-149
• 49 Misiek D, Kent J, Carr R. Soft tissue responses to hydroxylapatite particles of different shapes.  J Oral Maxillofac Surg . 1984;  42 150-160
• 50 Pettis G, Kaban L, Glowacki J. Tissue response to composite ceramic hydroxylapatite/demineralized bone implants.  J Oral Maxillofac Surg . 1990;  48 1068-1074
• 51 Bigata X, Ribera M, Bielsa I. et al . Adverse granulomatous reaction after cosmetic dermal silicone injection.  Dermatol Surg . 2001;  27 198-200
• 52 Milojevic B. Complication after silicone injection therapy in aesthetic plastic surgery.  Aesthet Plast Surg . 1982;  6 203-206
• 53 Hennekb R, Garus H J. Late complications following subcutaneous silicone injection.  Fortschr Ophthalmol . 1989;  86 249-250
• 54 Rapaport M J, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulitis, ulceration, and migration.  Aesth Plast Surg . 1996;  20 267
• 55 Senet B, Bachelez H, Ollivaud L. et al . Minocycline for treatment of cutaneous silicone granulomas.  Br J Dermatol . 1999;  140 985
• 56 Naoum C, Dasiou-Plakida D, Pantelidaki K. et al . A histological and immunohistochemical study of medical-grade fluid silicone.  Dermatol Surg . 1998;  24 867-870
• 57 Orentreich D S. Liquid injectable silicone: techniques for soft tissue augmentation.  Clin Plast Surg . 2000;  27 595-612
• 58 Webster R C, Gaunt J M, Hamdan U S. et al . Injectable silicone for facial soft tissue augmentation.  Arch Otolaryngol Head Neck Surg . 1986;  112 290-296